IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection

Journal of Immunology

Volumn 189, Issue 8, 2012, Pages 3925-3935

  Das, Abhishek ^a   Ellis, Gidon ^a   Pallant, Celeste ^a   Lopes, A Ross ^a   Khanna, Pooja ^a   Peppa, Dimitra ^a   Chen, Antony ^a   Blair, Paul ^a   Dusheiko, Geoffrey ^a   Gill, Upkar ^b   Kennedy, Patrick T ^b   Brunetto, Maurizia ^c   Lampertico, Pietro ^d   Mauri, Claudia ^a   Maini, Mala K ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF PISA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD24 ANTIGEN; CD38 ANTIGEN; INTERLEUKIN 10; VIRUS ANTIGEN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; EX VIVO STUDY; FEMALE; HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; IN VITRO STUDY; INTERLEUKIN 10 BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY B CELL; VIRUS CELL INTERACTION; VIRUS LOAD;

ADULT; AGED; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES, REGULATORY; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-10; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84867308365     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103139     Document Type: Article

References (57)

1. Evans, J. G., K. A. Chavez-Rueda, A. Eddaoudi, A. Meyer-Bahlburg, D. J. Rawlings, M. R. Ehrenstein, and C. Mauri. 2007. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178: 7868-7878. (Pubitemid 46898059)
2. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501. (Pubitemid 36278604)
3. Mizoguchi, A., E. Mizoguchi, H. Takedatsu, R. S. Blumberg, and A. K. Bhan. 2002. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16: 219-230. (Pubitemid 34211962)
4. Schioppa, T., R. Moore, R. G. Thompson, E. C. Rosser, H. Kulbe, S. Nedospasov, C. Mauri, L. M. Coussens, and F. R. Balkwill. 2011. B regulatory cells and the tumor-promoting actions of TNF-a during squamous carcinogenesis. Proc. Natl. Acad. Sci. USA 108: 10662-10667.
5. Yanaba, K., J. D. Bouaziz, K. M. Haas, J. C. Poe, M. Fujimoto, and T. F. Tedder. 2008. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650. (Pubitemid 351636247)
6. Yanaba, K., A. Yoshizaki, Y. Asano, T. Kadono, T. F. Tedder, and S. Sato. 2011. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am. J. Pathol. 178: 735-743.
7. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950. (Pubitemid 35154008)
8. Mauri, C. 2010. Regulation of immunity and autoimmunity by B cells. Curr. Opin. Immunol. 22: 761-767.
9. Madan, R., F. Demircik, S. Surianarayanan, J. L. Allen, S. Divanovic, A. Trompette, N. Yogev, Y. Gu, M. Khodoun, D. Hildeman, et al. 2009. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 183: 2312-2320.
10. Ronet, C., Y. Hauyon-La Torre, M. Revaz-Breton, B. Mastelic, F. Tacchini- Cottier, J. Louis, and P. Launois. 2010. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J. Immunol. 184: 886-894.
11. Ding, Q., M. Yeung, G. Camirand, Q. Zeng, H. Akiba, H. Yagita, G. Chalasani, M. H. Sayegh, N. Najafian, and D. M. Rothstein. 2011. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J. Clin. Invest. 121: 3645-3656.
12. Carter, N. A., R. Vasconcellos, E. C. Rosser, C. Tulone, A. Muñoz-Suano, M. Kamanaka, M. R. Ehrenstein, R. A. Flavell, and C. Mauri. 2011. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 186: 5569-5579.
13. Blair, P. A., L. Y. Noreña, F. Flores-Borja, D. J. Rawlings, D. A. Isenberg, M. R. Ehrenstein, and C. Mauri. 2010. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32: 129-140.
14. Bouaziz, J. D., S. Calbo, M. Maho-Vaillant, A. Saussine, M. Bagot, A. Bensussan, and P. Musette. 2010. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur. J. Immunol. 40: 2686-2691.
15. Iwata, Y., T. Matsushita, M. Horikawa, D. J. Dilillo, K. Yanaba, G. M. Venturi, P. M. Szabolcs, S. H. Bernstein, C. M. Magro, A. D. Williams, et al. 2011. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 117: 530-541.
16. Duddy, M., M. Niino, F. Adatia, S. Hebert, M. Freedman, H. Atkins, H. J. Kim, and A. Bar-Or. 2007. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178: 6092-6099. (Pubitemid 46717389)
17. Schurich, A., P. Khanna, A. R. Lopes, K. J. Han, D. Peppa, L. Micco, G. Nebbia, P. T. Kennedy, A. M. Geretti, G. Dusheiko, and M. K. Maini. 2011. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 53: 1494-1503.
18. Roederer, M., J. L. Nozzi, and M. C. Nason. 2011. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79: 167-174.
19. Peppa, D., L. Micco, A. Javaid, P. T. Kennedy, A. Schurich, C. Dunn, C. Pallant, G. Ellis, P. Khanna, G. Dusheiko, et al. 2010. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog. 6: e1001227.
20. Boni, C., P. Fisicaro, C. Valdatta, B. Amadei, P. Di Vincenzo, T. Giuberti, D. Laccabue, A. Zerbini, A. Cavalli, G. Missale, et al. 2007. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81: 4215-4225. (Pubitemid 46586915)
21. Maini, M. K., C. Boni, C. K. Lee, J. R. Larrubia, S. Reignat, G. S. Ogg, A. S. King, J. Herberg, R. Gilson, A. Alisa, et al. 2000. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191: 1269-1280. (Pubitemid 30227116)
22. Das, A., M. Hoare, N. Davies, A. R. Lopes, C. Dunn, P. T. Kennedy, G. Alexander, H. Finney, A. Lawson, F. J. Plunkett, et al. 2008. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J. Exp. Med. 205: 2111-2124.
23. Lopes, A. R., P. Kellam, A. Das, C. Dunn, A. Kwan, J. Turner, D. Peppa, R. J. Gilson, A. Gehring, A. Bertoletti, and M. K. Maini. 2008. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J. Clin. Invest. 118: 1835-1845. (Pubitemid 351632386)
24. Barr, T. A., S. Brown, G. Ryan, J. Zhao, and D. Gray. 2007. TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur. J. Immunol. 37: 3040-3053. (Pubitemid 350131284)
25. Lampropoulou, V., K. Hoehlig, T. Roch, P. Neves, E. Calderón Gómez, C. H. Sweenie, Y. Hao, A. A. Freitas, U. Steinhoff, S. M. Anderton, and S. Fillatreau. 2008. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 180: 4763-4773.
26. Lazdina, U., T. Cao, J. Steinbergs, M. Alheim, P. Pumpens, D. L. Peterson, D. R. Milich, G. Leroux-Roels, and M. Sällberg. 2001. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells. J. Virol. 75: 6367-6374. (Pubitemid 32578155)
27. Dunn, C., D. Peppa, P. Khanna, G. Nebbia, M. Jones, N. Brendish, R. M. Lascar, D. Brown, R. J. Gilson, R. J. Tedder, et al. 2009. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137: 1289-1300.
28. Tan, A. T., S. Koh, W. Goh, H. Y. Zhe, A. J. Gehring, S. G. Lim, and A. Bertoletti. 2010. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J. Hepatol. 52: 330-339.
29. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180: 5771-5777.
30. Couper, K. N., D. G. Blount, M. S. Wilson, J. C. Hafalla, Y. Belkaid, M. Kamanaka, R. A. Flavell, J. B. de Souza, and E. M. Riley. 2008. IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog. 4: e1000004.
31. Gazzinelli, R. T., M. Wysocka, S. Hieny, T. Scharton-Kersten, A. Cheever, R. Kühn, W. Müller, G. Trinchieri, and A. Sher. 1996. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157: 798-805. (Pubitemid 26231385)
32. Humphreys, I. R., C. de Trez, A. Kinkade, C. A. Benedict, M. Croft, and C. F. Ware. 2007. Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands. J. Exp. Med. 204: 1217-1225. (Pubitemid 46798163)
33. Brooks, D. G., A. M. Lee, H. Elsaesser, D. B. McGavern, and M. B. Oldstone. 2008. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J. Exp. Med. 205: 533-541. (Pubitemid 351439301)
34. Brooks, D. G., M. J. Trifilo, K. H. Edelmann, L. Teyton, D. B. McGavern, and M. B. Oldstone. 2006. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12: 1301-1309. (Pubitemid 44706933)
35. Ejrnaes, M., C. M. Filippi, M. M. Martinic, E. M. Ling, L. M. Togher, S. Crotty, and M. G. von Herrath. 2006. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203: 2461-2472. (Pubitemid 44664616)
36. Anderson, C. F., M. Oukka, V. J. Kuchroo, and D. Sacks. 2007. CD4(+)CD25(2) Foxp3(2) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204: 285-297. (Pubitemid 46294545)
37. Brockman, M. A., D. S. Kwon, D. P. Tighe, D. F. Pavlik, P. C. Rosato, J. Sela, F. Porichis, S. Le Gall, M. T. Waring, K. Moss, et al. 2009. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virusspecific T cells. Blood 114: 346-356.
38. Tu, Z., A. Bozorgzadeh, R. H. Pierce, J. Kurtis, I. N. Crispe, and M. S. Orloff. 2008. TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 205: 233-244. (Pubitemid 351185729)
39. Knolle, P. A., E. Schmitt, S. Jin, T. Germann, R. Duchmann, S. Hegenbarth, G. Gerken, and A. W. Lohse. 1999. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology 116: 1428-1440. (Pubitemid 29258892)
40. Manigold, T., and V. Racanelli. 2007. T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect. Dis. 7: 804-813. (Pubitemid 350152043)
41. Chang, J. J., A. J. Thompson, K. Visvanathan, S. J. Kent, P. U. Cameron, F. Wightman, P. Desmond, S. A. Locarnini, and S. R. Lewin. 2007. The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection. Hepatology 46: 1332-1340. (Pubitemid 350155514)
42. Xu, D., J. Fu, L. Jin, H. Zhang, C. Zhou, Z. Zou, J. M. Zhao, B. Zhang, M. Shi, X. Ding, et al. 2006. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 177: 739-747. (Pubitemid 43939189)
43. Alberti, A., S. Diana, G. H. Sculard, A. L. Eddleston, and R. Williams. 1978. Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. BMJ 2: 1056-1058. (Pubitemid 9026417)
44. Rosado, M. M., M. Scarsella, E. Pandolfi, S. Cascioli, E. Giorda, P. Chionne, E. Madonne, F. Gesualdo, M. Romano, C. M. Ausiello, et al. 2011. Switched memory B cells maintain specific memory independently of serum antibodies: the hepatitis B example. Eur. J. Immunol. 41: 1800-1808.
45. Oliviero, B., A. Cerino, S. Varchetta, E. Paudice, S. Pai, S. Ludovisi, M. Zaramella, G. Michelone, P. Pugnale, F. Negro, et al. 2011. Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections. J. Hepatol. 55: 53-60.
46. Lee, B. O., A. Tucker, L. Frelin, M. Sallberg, J. Jones, C. Peters, J. Hughes, D. Whitacre, B. Darsow, D. L. Peterson, and D. R. Milich. 2009. Interaction of the hepatitis B core antigen and the innate immune system. J. Immunol. 182: 6670-6681.
47. Matsue, K., S. Kimura, Y. Takanashi, K. Iwama, H. Fujiwara, M. Yamakura, and M. Takeuchi. 2010. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma. Cancer 116: 4769-4776.
48. Dhirapong, A., A. Lleo, G. X. Yang, K. Tsuneyama, R. Dunn, M. Kehry, T. A. Packard, J. C. Cambier, F. T. Liu, K. Lindor, et al. 2011. B cell depletion therapy exacerbates murine primary biliary cirrhosis. Hepatology 53: 527-535.
49. Neves, P., V. Lampropoulou, E. Calderon-Gomez, T. Roch, U. Stervbo, P. Shen, A. A. Kühl, C. Loddenkemper, M. Haury, S. A. Nedospasov, et al. 2010. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity 33: 777-790.
50. Bourke, E., D. Bosisio, J. Golay, N. Polentarutti, and A.Mantovani. 2003. The tolllike receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 102: 956-963. (Pubitemid 36917790)
51. Peng, S. L. 2005. Signaling in B cells via Toll-like receptors. Curr. Opin. Immunol. 17: 230-236. (Pubitemid 40692656)
52. Lampropoulou, V., E. Calderon-Gomez, T. Roch, P. Neves, P. Shen, U. Stervbo, P. Boudinot, S. M. Anderton, and S. Fillatreau. 2010. Suppressive functions of activated B cells in autoimmune diseases reveal the dual roles of Toll-like receptors in immunity. Immunol. Rev. 233: 146-161.
53. Sugalski, J. M., B. Rodriguez, S. Moir, and D. D. Anthony. 2010. Peripheral blood B cell subset skewing is associated with altered cell cycling and intrinsic resistance to apoptosis and reflects a state of immune activation in chronic hepatitis C virus infection. J. Immunol. 185: 3019-3027.
54. Malaspina, A., S. Moir, J. Ho, W. Wang, M. L. Howell, M. A. O'Shea, G. A. Roby, C. A. Rehm, J. M. Mican, T. W. Chun, and A. S. Fauci. 2006. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc. Natl. Acad. Sci. USA 103: 2262-2267. (Pubitemid 43271658)
55. Flaishon, L., R. Hershkoviz, F. Lantner, O. Lider, R. Alon, Y. Levo, R. A. Flavell, and I. Shachar. 2000. Autocrine secretion of interferon gamma negatively regulates homing of immature B cells. J. Exp. Med. 192: 1381-1388.
56. Shetty, S., T. Bruns, C. J. Weston, Z. Stamataki, Y. H. Oo, H. M. Long, G. M. Reynolds, G. Pratt, P. Moss, S. Jalkanen, et al. 2012. Recruitment mechanisms of primary and malignant B cells to the human liver. Hepatology. In press.
57. Palanichamy, A., J. Barnard, B. Zheng, T. Owen, T. Quach, C. Wei, R. J. Looney, I. Sanz, and J. H. Anolik. 2009. Novel human transitional B cell populations revealed by B cell depletion therapy. J. Immunol. 182: 5982-5993.